Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment
Part of paid clinical trials in Basking Ridge, New Jersey.
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Study ID
- NCT04106414
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Endometrial Adenocarcinoma
- Endometrial Carcinosarcoma
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Nivolumab — DRUGNivolumab 480 mg every 4 weeks.
- BMS- 986205 — DRUGBMS-986205 100 mg every 4 weeks.
Study Details
This study will compare the effects of treatment with nivolumab alone versus those of nivolumab plus the experimental drug BMS-986205. Adding BMS-986208 to nivolumab could shrink the cancer or prevent it from returning, but it could also cause side effects.
Key Dates
- Start date
- Sep 24, 2019
- Status verified
- Oct 2025
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 24 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Nivolumab aloneNivolumab 480 mg every 4 weeks.
- Experimental: Nivolumab with IDO-inhibitor, BMS- 986205Nivolumab 480 mg every 4 weeks with BMS-986205 100 mg.
Primary Outcome Measure
Response [ Time Frame: 1 year ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | New Jersey | 07920 | - |
| Memorial Sloan Kettering Monmouth | Middletown | New Jersey | 07748 | - |
| Memorial Sloan Kettering Bergen | Montvale | New Jersey | 07645 | - |
| Memorial Sloan Kettering Cancer Center @ Suffolk | Commack | New York | 11725 | - |
| Memorial Sloan Kettering Westchester | Harrison | New York | 10604 | - |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | - |
| Memorial Sloan Kettering Nassau | Uniondale | New York | 11553 | - |
Find similar trials in Basking Ridge, NJ
By research site
Memorial Sloan Kettering Basking Ridge· Basking Ridge, NJMemorial Sloan Kettering Monmouth· Middletown, NJMemorial Sloan Kettering Bergen· Montvale, NJMemorial Sloan Kettering Cancer Center @ Suffolk· Commack, NYMemorial Sloan Kettering Westchester· Harrison, NYMemorial Sloan Kettering Cancer Center· New York, NY
Related Studies
- Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaPHASE2 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaPHASE2 · Recruiting · Acrivon Therapeutics · Mobile, Alabama
- A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · Apollo Therapeutics Ltd · Duarte, California